跳至主要内容
临床试验/IRCT20221016056198N1
IRCT20221016056198N1招募中3 期

Comparision of corifollitropin alfa versus recombinant FSH in poor ovarian responders

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • Patients with hystory of previous cycle ;
  • that who fulfilled at least two of the following criteria were admitted: Antral follicle count (AFC) <?5;Antimullerian hormone (AMH)?<?1,1?ng/ml;Less than three oocytes obtained in the previous cycle;

排除标准

  • uterine abnormalities,
  • recent or current history of any current untreated endocrine abnormality,
  • unilateral or bilateral hydrosalpinx
  • contraindications for the use of gonadotropins

研究者

相似试验

evaluation the effect of Alnavar drug on patients... | 临床试验